OurCrowd

www.ourcrowd.com

OurCrowd invests across diverse sectors and stages with a sector, stage, and geography-agnostic approach, while maintaining particular strength in deep technology, AI, healthcare, and Israeli startups. The platform offers multiple investment vehicles including individual companies, diversified venture funds, and alternative assets like private credit and private equity.

Check Size

Not specified

Stages

Pre Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Ai Ml, Enterprise Saas, Vertical Saas

Is OurCrowd right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

OurCrowd is a global venture investing platform that democratizes private market access by providing accredited investors unprecedented access to pre-vetted startups, venture funds, and alternative assets traditionally reserved for institutions. The firm identifies and conducts extensive research on thousands of companies to recognize singular opportunities across sectors, stages, and geographies. As the most active venture investor in Israel since 2013, OurCrowd combines rigorous due diligence with a commitment to identifying high-potential emerging companies early in their lifecycle.

What Sets Them Apart

Democratizes venture investing by providing accredited individuals access to institutional-quality deals on the same terms as top-tier VCs
Israel's most active venture capital investor since 2013, with unprecedented ecosystem access and deal flow
Multi-dimensional diversification across sector, stage, geography, technology readiness level, and go-to-market approaches
Operates government-backed incubators (NGT Healthcare, Labs/02, Fresh Start, CanNegev, Sprout) providing seed funding and mentoring
Proven track record with 73 exits and $2.6B committed funds, including high-profile successes like Lemonade (8.6x return), Kenna Security (7.9x return)
Flexible investment options: individual companies, custom corporate funds, venture funds, and alternative assets
Comprehensive due diligence and 'Our Take' in-depth analysis for each investment opportunity